Boehringer Ingelheim taps Philogen DNA-encoded chemistry tech
Boehringer Ingelheim and Philogen have signed a multi-target research agreement to discover and optimize new small molecule therapeutics for unmet medical needs.
Archives for July 30, 2017
German lyophilisation ramp-up could be delayed into next year, Recipharm
A lyophilisation expansion announced in 2013 at an aseptic facility in Wasserburg, Germany has been delayed due to lengthy approval processes, says Recipharm.
Syngene expands Amgen collaboration as it recovers from fire incident
Syngene International is doubling the footprint of its research and development center following an expanded research collaboration with Amgen Inc.
Chiltern acquisition improves competitiveness of offerings, says Covance CEO
LabCorp has acquired Chiltern for $1.2bn to create a global contract research organization (CRO) with more than 20,000 employees.
Merck & Co API operations hit by cyberattack yet to restart production
API operations hit by the Petya cyberattack have not been restored according to Merck & Co Inc, which expects difficulties fulfilling some product orders and lower 2017 profits partly due to the hack.
Takeda licenses Zejula in deal that will see Tesaro supply it with API
Takeda has agreed to pay $100m (€85m) upfront for rights to make and sell to Tesaro Inc’s drug Zejula in Japan, South Korea, Taiwan, Russia and Australia.